81 related articles for article (PubMed ID: 17695542)
1. Signal transducer and activator of transcription 1 in breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Huang CC; Tang RP; Yang CH; Chou FF; Eng HL
Anticancer Res; 2007; 27(4B):2481-6. PubMed ID: 17695542
[TBL] [Abstract][Full Text] [Related]
2. Lack of prognostic value of insulin-like growth factor-1 in patients with breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Chou FF; Hsu W; Huang CC; Eng HL; Tang RP
Anticancer Res; 2007; 27(5B):3541-4. PubMed ID: 17972515
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of signal transducers and activators of transcription 3 in breast cancer.
Sheen-Chen SM; Huang CC; Tang RP; Chou FF; Eng HL
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2286-90. PubMed ID: 18768494
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-binding protein-3 in breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Zhang H; Huang CC; Tang RP
Anticancer Res; 2009 Apr; 29(4):1131-5. PubMed ID: 19414355
[TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
Nevalainen MT; Xie J; Torhorst J; Bubendorf L; Haas P; Kononen J; Sauter G; Rui H
J Clin Oncol; 2004 Jun; 22(11):2053-60. PubMed ID: 15169792
[TBL] [Abstract][Full Text] [Related]
6. Lack of prognostic value of topoisomerase II alpha in patients with breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Huang CY; Zhang H; Huang CC; Tang RP
Anticancer Res; 2010 Jun; 30(6):2459-62. PubMed ID: 20651408
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of fatty acid-CoA ligase 4 in breast cancer.
Tsai CH; Sheen-Chen SM; Huang CY; Chen YJ; Chi SY; Ko SF; Lee YW; Liang JL; Hsu HW; Huang EY; Chen HC; Huang CC; Rau KM; Tang RP
Anticancer Res; 2014 Mar; 34(3):1239-43. PubMed ID: 24596366
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of hepatocyte growth factor in patients with breast cancer.
Sheen-Chen SM; Liu YW; Eng HL; Chou FF
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of focal adhesion kinase in breast cancer by tissue microarrays.
Sheen-Chen SM; Huang CY; Chan YC; Tsai CH; Chi SY; Wu SC; Huang CC; Tang RP; Eng HL; Ko SF; Lee YW; Liang JL; Huang EY; Chen HC; Rau KM
Anticancer Res; 2013 Mar; 33(3):1169-73. PubMed ID: 23482798
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
Harigopal M; Heymann J; Ghosh S; Anagnostou V; Camp RL; Rimm DL
Breast Cancer Res Treat; 2009 May; 115(1):77-85. PubMed ID: 18521745
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of prognostic value of death-associated protein kinase 1 in breast cancer.
Chou SE; Huang CY; Sheen-Chen SM; Liu YW; Tsai CH; Lin YH; Huang CC; Tang RP
Anticancer Res; 2011 Oct; 31(10):3633-6. PubMed ID: 21965790
[TBL] [Abstract][Full Text] [Related]
12. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
[TBL] [Abstract][Full Text] [Related]
13. Cortactin in breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Huang CY; Liu YY; Huang CC; Tang RP
Anticancer Res; 2011 Jan; 31(1):293-7. PubMed ID: 21273613
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between expression of macrophage migration inhibitory factor and prognosis of breast cancer].
Xu XD; Yao C; Lin Y; Wang LP; Ma LL; Wang SM
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):520-3. PubMed ID: 18649765
[TBL] [Abstract][Full Text] [Related]
15. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
Arnes JB; Bégin LR; Stefansson I; Brunet JS; Nielsen TO; Foulkes WD; Akslen LA
J Clin Pathol; 2009 Feb; 62(2):139-46. PubMed ID: 18682421
[TBL] [Abstract][Full Text] [Related]
16. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
17. HYOU1/Orp150 expression in breast cancer.
Stojadinovic A; Hooke JA; Shriver CD; Nissan A; Kovatich AJ; Kao TC; Ponniah S; Peoples GE; Moroni M
Med Sci Monit; 2007 Nov; 13(11):BR231-239. PubMed ID: 17968289
[TBL] [Abstract][Full Text] [Related]
18. Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: a tissue microarray immunophenotypic analysis on 98 patients.
Florena AM; Tripodo C; Guarnotta C; Ingrao S; Porcasi R; Martorana A; Lo Bosco G; Cabibi D; Franco V
Pathobiology; 2007; 74(6):317-22. PubMed ID: 18087195
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
[TBL] [Abstract][Full Text] [Related]
20. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
